Literature DB >> 19906927

Herpes simplex virus type 1 (HSV-1)-induced apoptosis in human dendritic cells as a result of downregulation of cellular FLICE-inhibitory protein and reduced expression of HSV-1 antiapoptotic latency-associated transcript sequences.

Angela Kather1, Martin J Raftery, Gayathri Devi-Rao, Juliane Lippmann, Thomas Giese, Rozanne M Sandri-Goldin, Günther Schönrich.   

Abstract

Herpes simplex virus type 1 (HSV-1) is one of the most frequent and successful human pathogens. It targets immature dendritic cells (iDCs) to interfere with the antiviral immune response. The mechanisms underlying apoptosis of HSV-1-infected iDCs are not fully understood. Previously, we have shown that HSV-1-induced apoptosis of iDCs is associated with downregulation of the cellular FLICE-inhibitory protein (c-FLIP), a potent inhibitor of caspase-8-mediated apoptosis. In this study, we prove that HSV-1 induces degradation of c-FLIP in a proteasome-independent manner. In addition, by using c-FLIP-specific small interfering RNA (siRNA) we show for the first time that downregulation of c-FLIP expression is sufficient to drive uninfected iDCs into apoptosis, underlining the importance of this molecule for iDC survival. Surprisingly, we also observed virus-induced c-FLIP downregulation in epithelial cells and many other cell types that do not undergo apoptosis after HSV-1 infection. Microarray analyses revealed that HSV-1-encoded latency-associated transcript (LAT) sequences, which can substitute for c-FLIP as an inhibitor of caspase-8-mediated apoptosis, are much less abundant in iDCs as compared to epithelial cells. Finally, iDCs infected with an HSV-1 LAT knockout mutant showed increased apoptosis when compared to iDCs infected with the corresponding wild-type HSV-1. Taken together, our results demonstrate that apoptosis of HSV-1-infected iDCs requires both c-FLIP downregulation and diminished expression of viral LAT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906927      PMCID: PMC2798353          DOI: 10.1128/JVI.01409-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

Review 1.  Peculiarities of herpes simplex virus (HSV) transcription: an overview.

Authors:  Július Rajcáni; Vojvodová Andrea; Rezuchová Ingeborg
Journal:  Virus Genes       Date:  2004-04       Impact factor: 2.332

2.  Immediate-early expression of the herpes simplex virus type 1 ICP27 transcript is not critical for efficient replication in vitro or in vivo.

Authors:  Aixu Sun; G V Devi-Rao; M K Rice; L W Gary; D C Bloom; R M Sandri-Goldin; P Ghazal; E K Wagner
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  Herpes simplex virus type 1 immediate-early gene expression is required for the induction of apoptosis in human epithelial HEp-2 cells.

Authors:  Christine M Sanfilippo; Fungai N W Chirimuuta; John A Blaho
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

4.  The bovine herpesvirus-1 LR ORF2 is critical for this gene's ability to restore the high wild-type reactivation phenotype to a herpes simplex virus-1 LAT null mutant.

Authors:  Kevin R Mott; Nelson Osorio; Ling Jin; David J Brick; Julie Naito; Jennifer Cooper; Gail Henderson; Melissa Inman; Clinton Jones; Steven L Wechsler; Guey-Chuen Perng
Journal:  J Gen Virol       Date:  2003-11       Impact factor: 3.891

5.  E1A sensitizes cells to tumor necrosis factor alpha by downregulating c-FLIP S.

Authors:  Denise Perez; Eileen White
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

6.  Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunity.

Authors:  Gabriele Pollara; Katharina Speidel; Laila Samady; Mansi Rajpopat; Yvonne McGrath; Jonathan Ledermann; Robert S Coffin; David R Katz; Benjamin Chain
Journal:  J Infect Dis       Date:  2003-01-06       Impact factor: 5.226

7.  Identification of herpes simplex virus type 1 latency-associated transcript sequences that both inhibit apoptosis and enhance the spontaneous reactivation phenotype.

Authors:  Ling Jin; Weiping Peng; Guey-Chuen Perng; David J Brick; Anthony B Nesburn; Clinton Jones; Steven L Wechsler
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  Regulation of caspase 8- and caspase 9-induced apoptosis by the herpes simplex virus type 1 latency-associated transcript.

Authors:  Gail Henderson; Weiping Peng; Ling Jin; Guey-Chuen Perng; Anthony B Nesburn; Steven L Wechsler; Clinton Jones
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

Review 9.  Apoptosis prevention as a mechanism of immune evasion.

Authors:  Martine Aubert; Keith R Jerome
Journal:  Int Rev Immunol       Date:  2003 Sep-Dec       Impact factor: 5.311

10.  Frontline: Induction of apoptosis and modulation of c-FLIPL and p53 in immature dendritic cells infected with herpes simplex virus.

Authors:  Dagmar B Müller; Martin J Raftery; Angela Kather; Thomas Giese; Günther Schönrich
Journal:  Eur J Immunol       Date:  2004-04       Impact factor: 5.532

View more
  21 in total

Review 1.  CD8+ T cells patrol HSV-1-infected trigeminal ganglia and prevent viral reactivation.

Authors:  Anthony J St Leger; Robert L Hendricks
Journal:  J Neurovirol       Date:  2011-12-08       Impact factor: 2.643

2.  The herpes simplex virus 1 latency-associated transcript promotes functional exhaustion of virus-specific CD8+ T cells in latently infected trigeminal ganglia: a novel immune evasion mechanism.

Authors:  Aziz A Chentoufi; Elizabeth Kritzer; Michael V Tran; Gargi Dasgupta; Chang Hyun Lim; David C Yu; Rasha E Afifi; Xianzhi Jiang; Dale Carpenter; Nelson Osorio; Chinhui Hsiang; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

3.  Herpes simplex virus type 1-induced FasL expression in human monocytic cells and its implications for cell death, viral replication, and immune evasion.

Authors:  Alexandre Iannello; Olfa Debbeche; Raoudha El Arabi; Suzanne Samarani; David Hamel; Flore Rozenberg; Nikolaus Heveker; Ali Ahmad
Journal:  Viral Immunol       Date:  2011-02       Impact factor: 2.257

4.  Cutaneous RANK-RANKL Signaling Upregulates CD8-Mediated Antiviral Immunity during Herpes simplex Virus Infection by Preventing Virus-Induced Langerhans Cell Apoptosis.

Authors:  Lars Klenner; Wali Hafezi; Björn E Clausen; Eva U Lorentzen; Thomas A Luger; Stefan Beissert; Joachim E Kühn; Karin Loser
Journal:  J Invest Dermatol       Date:  2015-06-15       Impact factor: 8.551

5.  The ribonucleotide reductase R1 subunits of herpes simplex virus 1 and 2 protect cells against poly(I · C)-induced apoptosis.

Authors:  Florent Dufour; Luc Bertrand; Angela Pearson; Nathalie Grandvaux; Yves Langelier
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

6.  Heliothis zea nudivirus 1 gene hhi1 induces apoptosis which is blocked by the Hz-iap2 gene and a noncoding gene, pag1.

Authors:  Yueh-Lung Wu; Carol P Wu; Catherine Y Y Liu; Song-Tay Lee; Hsiao-Ping Lee; Yu-Chan Chao
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

7.  Direct cleavage of caspase-8 by herpes simplex virus 1 tegument protein US11.

Authors:  Maria Musarra-Pizzo; Rosamaria Pennisi; Daniele Lombardo; Tania Velletri; Maria Teresa Sciortino
Journal:  Sci Rep       Date:  2022-07-19       Impact factor: 4.996

8.  Herpes simplex virus 2 (HSV-2) prevents dendritic cell maturation, induces apoptosis, and triggers release of proinflammatory cytokines: potential links to HSV-HIV synergy.

Authors:  Martha Stefanidou; Irene Ramos; Veronica Mas Casullo; Janie B Trépanier; Sara Rosenbaum; Ana Fernandez-Sesma; Betsy C Herold
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

Review 9.  Pathobiology and treatment of viral keratitis.

Authors:  Raghuram Koganti; Tejabhiram Yadavalli; Raza Ali Naqvi; Deepak Shukla; Afsar R Naqvi
Journal:  Exp Eye Res       Date:  2021-02-06       Impact factor: 3.467

10.  Regulatory dendritic cells: there is more than just immune activation.

Authors:  Susanne V Schmidt; Andrea C Nino-Castro; Joachim L Schultze
Journal:  Front Immunol       Date:  2012-09-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.